- Home
- TARS vs CUBI Comparison
TARS vs CUBI Comparison
Compare TARS & CUBI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TARS
- CUBI
- Stock Information
- Founded
- TARS 2016
- CUBI 1994
- Country
- TARS United States
- CUBI United States
- Employees
- TARS N/A
- CUBI N/A
- Industry
- TARS Medicinal Chemicals and Botanical Products
- CUBI Major Banks
- Sector
- TARS Health Care
- CUBI Finance
- Exchange
- TARS Nasdaq
- CUBI Nasdaq
- Market Cap
- TARS 1.8B
- CUBI 1.8B
- IPO Year
- TARS 2020
- CUBI 2012
- Fundamental
- Price
- TARS $53.26
- CUBI $51.51
- Analyst Decision
- TARS Strong Buy
- CUBI Buy
- Analyst Count
- TARS 5
- CUBI 9
- Target Price
- TARS $54.20
- CUBI $63.88
- AVG Volume (30 Days)
- TARS 469.2K
- CUBI 257.0K
- Earning Date
- TARS 11-13-2024
- CUBI 01-23-2025
- Dividend Yield
- TARS N/A
- CUBI N/A
- EPS Growth
- TARS N/A
- CUBI N/A
- EPS
- TARS N/A
- CUBI 6.16
- Revenue
- TARS $129,621,000.00
- CUBI $672,806,000.00
- Revenue This Year
- TARS $895.24
- CUBI N/A
- Revenue Next Year
- TARS $73.78
- CUBI $7.91
- P/E Ratio
- TARS N/A
- CUBI $8.66
- Revenue Growth
- TARS 801.96
- CUBI 9.04
- 52 Week Low
- TARS $18.84
- CUBI $42.31
- 52 Week High
- TARS $54.44
- CUBI $68.49
- Technical
- Relative Strength Index (RSI)
- TARS 64.67
- CUBI 41.61
- Support Level
- TARS $48.45
- CUBI $51.91
- Resistance Level
- TARS $53.85
- CUBI $54.90
- Average True Range (ATR)
- TARS 2.40
- CUBI 1.48
- MACD
- TARS -0.14
- CUBI -0.65
- Stochastic Oscillator
- TARS 80.30
- CUBI 3.91
About TARS Tarsus Pharmaceuticals Inc.
Tarsus Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the development and commercialization of therapeutics, starting with eye care. It is focused on the development and commercialization of first-in-class therapeutic candidates to provide treatment for ophthalmic conditions. The company's candidate XDEMVY is a novel investigational eye drop to treat blepharitis caused by the infestation of Demodex mites, referred to as Demodex blepharitis.
About CUBI Customers Bancorp Inc
Customers Bancorp Inc is a bank holding company engaged in banking activities. It provides financial products and services to small and middle-market businesses, not-for-profits, and consumers. The company operates in Lending Activities, Commercial Lending, Consumer Lending, Private Banking, Deposit Products, Other Funding Sources, and Financial Products and Services. The majority of revenue is derived from commercial lending.